Alpha adrenergic receptors location and effects highlighted in pharmacology charts.
Phharmacological management of hypertension: by the Pharmacology OpenCourseWare initiative at Harvard Medical School – MIT.
ACE inhibitors and angiotensin II receptor blockers should be avoided in pregnancy and during breastfeeding
UK’s MHRA: do not to use ACE inhibitors and angiotensin II receptor antagonists while breastfeeding. Hypertension Journal reviews ACEI toxicity in pregnancy.
ACCOMPLISH trial analyzed by the NPC team, independent and unbiased information relevant to medical practice.
The following set of lectures has been created by Dr. Edwin Jackson and were published in the Division for Cardiovascular Pharmacology, a branch of the American Society for Pharmacology and Experimental Therapeutics (ASPET). Part 1: How diuretics work Download: DIURETICS Part 1 – How they work. PPT file Part 2: What do diuretics do Na-K-2Cl […]
The National Prescribing Service Limited (Australia) issues a publication called NPS RADAR. In this issue valsartan (Diovan) is reviewed, this is the summary: Valsartan reduces blood pressure to a similar extent as other angiotensin II-receptor antagonists. If blood pressure is not controlled by valsartan 160 mg, add a second drug rather than increasing the dose […]
PowerPoint presentation on cardiovascular pharmacology for nurses. Drugs to treat hypertension, heart failure, MI, shock and arrhythmias reviewed
The following cardiovascular pharmacology presentation is a practical overview on hypertension, drugs used in heart failure, MI, shock and antiarrhythmics: More on nursing pharmacology
The following pharmacology PowerPoint has been developed by Ed Sheridan, Pharm.D. Outline: ACE inhibitors, Angiotensin II Receptor Blockers (ARBs), and calcium channel blockers •Review the Mechanism of Action •Review Safety •Review Efficacy •Hypertension Download ppt slides: pharmacology of ACEi, ARBs, and Calcium channel blockers. You may also find interesting related PowerPoint presentation on drug therapy […]
According to the EMEA, aliskiren (Rasilez, Tekturna in the USA) should not be prescribed in patients that experienced angioedema after taking the drug. Some excerpts from the EMEA press release dated 19 February, 2009: The European Medicines Agency (EMEA) has recommended adding a contraindication to the Product Information for aliskiren, stating that it must not […]